Actinium Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.About ATNM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients.
CEOSandesh Seth
CEOSandesh Seth
Employees37
Employees37
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2000
Founded2000
Employees37
Employees37
ATNM Key Statistics
Market cap45.39M
Market cap45.39M
Price-Earnings ratio-1.28
Price-Earnings ratio-1.28
Dividend yield—
Dividend yield—
Average volume152.76K
Average volume152.76K
High today$1.48
High today$1.48
Low today$1.41
Low today$1.41
Open price$1.41
Open price$1.41
Volume88.66K
Volume88.66K
52 Week high$2.41
52 Week high$2.41
52 Week low$1.03
52 Week low$1.03
Stock Snapshot
The current Actinium Pharmaceuticals(ATNM) stock price is $1.45, with a market capitalization of 45.39M. The stock trades at a price-to-earnings (P/E) ratio of -1.28.
On 2025-12-11, Actinium Pharmaceuticals(ATNM) stock moved within a range of $1.41 to $1.48. With shares now at $1.45, the stock is trading +2.8% above its intraday low and -1.7% below the session's peak.
Trading volume for Actinium Pharmaceuticals(ATNM) stock has reached 88.66K, versus its average volume of 152.76K.
Over the past 52 weeks, Actinium Pharmaceuticals(ATNM) stock has traded between a high of $2.41 and a low of $1.03.
Over the past 52 weeks, Actinium Pharmaceuticals(ATNM) stock has traded between a high of $2.41 and a low of $1.03.
People also own
Based on the portfolios of people who own ATNM. This list is generated using Robinhood data, and it’s not a recommendation.